Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 13th Annual Clinical Pharmacology Research Award

Tokyo, Japan (June 15, 2020) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Kazunori Hirokawa), has awarded its 13th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.

Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.

The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 18, 2020.

*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.

Recipients of the 13th Japan Research Foundation for Clinical Pharmacology Research Award




Research theme

Ushijima Kentaro

Division of Pharmaceutics, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University/Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University

PK/PD/PG analysis of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension

Osumi Tomoo

Children's Cancer Center, National Center for Child Health and Development

The optimization in busulfan-based conditioning on hematopoietic stem cell transplantation for children

Kaneda-Kubo Michiko

Department of Obstetrics and Gynecology, Mie University School of Medicine

Development of tadalafil treatment for fetuses with fetal growth restriction

Doki Kosuke

Department of Pharmaceutical Sciences, Faculty of Medicine, University of Tsukuba

Use of pharmacogenetic information for therapeutic drug monitoring of propafenone

Hirai Keita

Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka

Development of biomarkers to stratify drug therapy for patients with COPD